By Iain Wilkie
08 March 2022, 12:00 PM
The US Patent Office (USTPO) has issued a final rejection notice for Paradigm Biopharmaceuticals' (ASX:PAR) key osteoarthritis patent application.
Read more...
By Scott Power
09 September 2014, 9:24 AM
A buying opportunity
Read more...
By Scott Power
07 July 2014, 10:41 AM
Rising investor interest
Read more...
By Scott Power
12 June 2014, 9:02 AM
A stand out presentation at Asia BiotechInvest 2014
Read more...
By Scott Power
13 May 2014, 10:40 AM
Funding complete
Read more...
By Scott Power
06 March 2014, 1:39 PM
Big shoes to fill
Read more...
By Scott Power
10 December 2013, 10:46 AM
Put your trading hat on
Read more...
By Scott Power
22 November 2013, 10:08 AM
We have listed our five best life science stocks for your Christmas stocking.
Read more...
By Scott Power
18 November 2013, 2:51 PM
Anticipating a share price rally following the close of the SPP
Read more...
By Scott Power
29 October 2013, 7:20 AM
Key takeaways from day one of the 2013 conference
Read more...